Medical Microbiology articles for Japan

Time frame: 1 July 2025 - 30 June 2026

View topic

Count: 38

Article ‘Count’ for Medical Microbiology.

Journal Count Share
1 0.66
Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia 0.66
1 1.00
Enzymatic oxygen reduction dominates overpotential-driven thermogenesis in mitochondria 1.00
5 0.99
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection 0.60
Utility of Repeating Blood Cultures in Candidemia: Insights From 2 Large Clinical Data Repositories 0.19
Changes in Epidemiology of Candidemia in the United States With a Focus on Candida auris 0.07
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial 0.07
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years 0.05
3 1.13
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study 0.07
Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota 1.00
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.06
1 0.08
Microemulsion-Assisted Synthesis of Ni(II)-Grafted Cellulose Metallogel: Structural Insights into a High-Performance β-Lactamase Inhibitor 0.08
1 1.00
A bacterial actin with high ATPase activity regulates the polymerization of a partner MreB isoform essential for Spiroplasma swimming motility 1.00
1 0.13
Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells 0.13
6 5.88
The small non-coding RNA, RsaC, is essential for Staphylococcus aureus virulence 1.00
In Vitro Selection and Characterization of Tecovirimat-resistant Mpox Virus 0.93
Long-term outcomes of chronic active Epstein-Barr virus infection in childhood after dominantly infected lymphocyte subpopulation management 1.00
Nucleolar targeting by Oropouche virus nonstructural protein mediates RNA polymerase II degradation and interferon antagonism 0.95
Respiratory syncytial virus–mediated Gas6/Axl axis induces hyporesponsive macrophages to promote pneumococcal proliferation in the nasopharynx 1.00
Respiratory Syncytial Virus Fusion Protein Epitope-Specific Antibodies and Neutralizing Activities Against Various Respiratory Syncytial Virus Strains 1.00
1 0.97
Host control of persistent Epstein–Barr virus infection 0.97
7 3.70
Structure of ergosteryl-aspartate synthase reveals how an entrapped tRNA is used like a prosthetic swinging arm in the synthesis of aminoacylated sterols 0.30
Structural and mechanistic insights into the inhibition of Plasmodium falciparum MDR1 0.07
A multifaceted model of Entamoeba histolytica KERP2 regulating gene expression and host cell responses 1.00
Precise gene regulation through transcriptional repression is essential for Plasmodium berghei asexual blood stage development 1.00
Saffold virus exploits integrin αvβ8 and sulfated glycosaminoglycans as cooperative attachment receptors for infection 1.00
Conformational plasticity across phylogenetic clusters of RND multidrug efflux pumps and its impact on substrate specificity 0.20
Colistin enhances caspofungin antifungal efficacy against by modulating calcium homeostasis and stress responses 0.13
4 1.35
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus 0.23
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence 0.08
Identification of claudin-3 as an entry factor for rat hepacivirus 1.00
Fatty acid 2-hydroxylase facilitates rotavirus uncoating and endosomal escape 0.04
1 0.08
Dynamic shift in the dominant transmission route of clade Ib monkeypox virus across networks with sexual and nonsexual contacts 0.08
1 0.68
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo 0.68
1 0.50
“Paraxenoviridae”, a putative family of globally distributed marine bacteriophages with double-stranded RNA genomes 0.50
1 1.00
Molecular Insight into the Hepatitis B Virus: Coarse-Grained Simulations of the Envelope–Capsid Complex 1.00
3 0.65
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.06
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts 0.50
Clesrovimab for Prevention of RSV Disease in Healthy Infants 0.08

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.